drugset / Trial / NCT00390039
Efficacy and Safety of Intranasal Morphine for Pain After Elective Orthopedic Surgery
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Multiple-center, multiple-dose, randomized, double-blind, six-arm, active- and placebo-controlled study in patients with moderate to severe post-surgical pain from elective orthopedic surgery with safety observed for a total of 30 hours post first dose.
Timeline
- Start
- 2006-05
- Primary completion
- 2006-09
- Completion
- 2006-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Morphine | Other / unclassified | 7.5 mg | Intranasal |
| Subject | Morphine | Other / unclassified | 15 mg | Intranasal |
Indications
No indication recorded.